Jardiance vs. Ozempic
See how Jardiance and Ozempic compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Jardiance is a once-daily pill while Ozempic is a once-weekly injection, so the two fit very different daily routines.
Jardiance lowers blood sugar by removing glucose through urine, while Ozempic mimics a gut hormone that slows digestion and reduces appetite.
Both drugs cut cardiovascular risk in type 2 diabetes with heart disease and slow chronic kidney disease, but only Ozempic is associated with significant weight loss.
Jardiance vs. Ozempic Drug Summary
Jardiance
Jardiance (empagliflozin) is an SGLT2 inhibitor used to control blood sugar in type 2 diabetes and to lower cardiovascular and kidney risks. It comes as a once-daily oral tablet that can be taken with or without food.
Ozempic
Ozempic (semaglutide) is a GLP-1 receptor agonist used to control blood sugar in type 2 diabetes and reduce cardiovascular risk in people with heart disease. It is injected under the skin once a week, with the dose increased gradually over several weeks.
Jardiance vs. Ozempic Side Effects
Jardiance
Ozempic
Jardiance vs. Ozempic Dosage
Jardiance
Ozempic
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 0.5 mg once weekly | Week 5 onward |
| Dose changes | 1 increase | Every 4 weeks |
Jardiance
| STAGE | DOSE | WHEN |
| Starting dose | 10 mg once daily | At the start |
| Maximum dose | 25 mg once daily | If needed |
| Dose changes | 1 increase | As tolerated |
Ozempic
| STAGE | DOSE | WHEN |
| Starting dose | 0.25 mg once weekly | Weeks 1-4 |
| Maximum dose | 0.5 mg once weekly | Week 5 onward |
| Dose changes | 1 increase | Every 4 weeks |
Jardiance vs. Ozempic Indications
Jardiance
Jardiance is FDA-approved for blood sugar control in adults and children 10 and older with type 2 diabetes. It is also approved to reduce cardiovascular death risk in adults with heart disease, to reduce cardiovascular death and hospitalization in heart failure, and to slow chronic kidney disease progression.
Blood sugar control in type 2 diabetes (adults and children 10+)
Reduce cardiovascular death risk with heart disease
Reduce cardiovascular death and hospitalization in heart failure
Slow chronic kidney disease progression
Ozempic
Ozempic is FDA-approved for blood sugar control in adults with type 2 diabetes, used alongside diet and exercise. It also reduces the risk of major cardiovascular events in people with type 2 diabetes and known heart disease, and slows kidney damage progression in those with chronic kidney disease.
Blood sugar control in type 2 diabetes (adults)
Reduce major cardiovascular events with heart disease
Slow kidney damage progression with chronic kidney disease
Off-label: weight loss in people without diabetes (not FDA-approved for this use)
Jardiance vs. Ozempic Pros and Cons
Jardiance
Jardiance is a once-daily pill, appealing to those who prefer to avoid injections. It has been studied for years in heart failure and chronic kidney disease, giving it a broader set of approved uses beyond blood sugar control. Its main risks are genital infections and, rarely, diabetic ketoacidosis even without high blood sugar.
Pros
Oral tablet, no injections needed
Approved for heart failure regardless of ejection fraction
Approved for pediatric patients 10 and older
Cons
Risk of genital yeast infections and UTIs
Small risk of diabetic ketoacidosis even without high blood sugar
Not linked to significant weight loss like GLP-1 drugs
Risk of dehydration and low blood pressure in older adults
Ozempic
Ozempic requires only one injection per week, but nausea and other digestive side effects are common, especially during dose increases. It carries a boxed warning for thyroid C-cell tumors seen in animal studies and is not recommended for those with a personal or family history of certain thyroid cancers. Many people also see meaningful weight loss on the medication, though it is not FDA-approved specifically for that use.
Pros
Only needs to be taken once a week
Often leads to meaningful weight loss
Approved to slow kidney damage progression with chronic kidney disease
Cons
Boxed warning for thyroid C-cell tumor risk in animal studies
Common nausea, vomiting, and digestive side effects
Not approved for chronic weight management (that indication belongs to Wegovy)
Roughly $935 to $1,043 per month without insurance
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.